Mr. David (Xiaoying) Gao, Chief Executive Officer

Mr. Gao has served as BMP Sunstone’s Chief Executive Officer and one of our directors since February 2004. Previously he served as President and Chief Executive Officer of Abacus Investments, Ltd., a private wealth management company, from 2003 to 2004. From 1989 to 2002, Mr. Gao held various senior posts at Motorola including Vice President and Director, Integrated Electronic System Sector, Asia-Pacific operation; Motorola Asia Pacific Management Board, Management Board of Motorola Japan Ltd. and Motorola China Management Board.

Mr. Gao holds a BSC in Mechanical Engineering from the Beijing Institute of Technology, a BSC in Mechanical Engineering from Hanover University, Germany, and an M.B.A. from The Massachusetts Institute of Technology.

Mr. Zhiqiang Han, President

Mr. Han has served as BMP Sunstone’s President of China Operations and one of our directors since February 2008. Mr. Han is the founder of Sunstone (Tangshan) Pharmaceutical Corporation, Ltd. and served as Chairman and General Manager since 1996. From 1993 until1996, Mr. Han served as Managing Director of Tangshan Changrong Pharmaceuticals. Previously, Mr. Han was the Chief EngineerLogistic Dept Head/Assistant to the Plant Director in Tangshan Women and Children Pharmaceutical Manufacturer. Mr. Han serves as Vice President of China Nonprescription Medicine Association; Chairman of Heibei Industry and Economic Union; and Vice President of Hebei Pharmaceutical Industry Association.

Mr. Han has a Bachelor of Science degree from Shenyang Pharmaceutical University and an MBA from Dalian University of Technology.

Fred Powell, Chief Finance Officer

Mr. Powell has served as BMP Sunstone’s Chief Financial Officer since January 2005. And prior to this, he had been with Eximias Pharmaceutical Corporation as the CFO since May 2002. He was Senior Vice President, Finance and Administration, at InnaPhase where he was mainly responsible for all financial, internal control, HR, administrative, and legal affairs. At Premier Research Worldwide (PRWW), Mr. Powell served as CFO and helped PRWW become one of the nation’s leading clinical research organizations by leading the Company’s initial public offering and managing several acquisitions, including DLB, a clinical trial and data management software company.

From 1983 to 1989, Mr. Powell spent seven years at KPMG Peat Marwick as a Senior Manager responsible for directing the planning, coordination and deliver of audit management and technology services to clients in the pharmaceutical and services industries.

Mr. Powell graduated from Penn State University in 1983, with a Bachelor of Sciences in Accounting and is a Certified Public Accountant.

Ms. Yanping Zhao, Vice President

Ms. Zhao has served as BMP Sunstone’s Corporate Vice President since October 2007. From 1992 until 2007, Ms. Zhao held various senior positions with Sino Biopharmaceutical Ltd, where she held senior posts of Vice President and Executive Director in the Corporation, Executive Director in Shandong Chia Tai Freda Pharmaceutical Ltd, as well as Managing Director of its subsidiaries. Ms. Zhao also served as Department Head at Inner Mongolia Medicine and Health Products Import Export Corporation, and Deputy Plan Manager at Inner Mongolia Yuanbaoshan Pharmaceutical Ltd during 1983 to 1992.

Ms. Zhao has a Pharmaceutical degree from Shenyang Pharmaceutical University and a MBA from Dalian University of Technology.

Martyn D. Greenacre
Chairman - Former Chairman, Europe, SmithKline Beecham

Martyn Greenacre has served as Chairman of the Board of Beijing Med-Pharm since July 2004. Since 2002, Mr. Greenacre has also served as Chairman of Life Mist LLC, a fire suppression equipment company. From 1997 to 2001 Mr. Greenacre served as Chief Executive Officer and director of Delsys Pharmaceutical Corporation, a formulation and drug delivery system company. From 1993 to 1997, Mr. Greenacre served as President and Chief Executive Officer of Zynaxis Inc., a biopharmaceutical company. From 1989 to 1992, Mr. Greenacre was Chairman Europe, SmithKline Beecham Pharmaceutical company. Mr. Greenacre joined Smith Kline & French in 1973, where he held positions of increasing responsibility in its European organization. Mr. Greenacre currently serves as a director of Acusphere, Inc., a drug delivery company, Cephalon Inc., a pharmaceutical company, Curis Inc., a biotechnology company, and Immune Response Corp, a vaccine company.

Jack M. Ferraro
Director - Former Director of Neuberger Berman

Jack M. Ferraro has served as one of our directors since February 2004. Mr. Ferraro is a private investor. From 1979 to 2000, he served as money manager and partner of Neuberger Berman, LLC, a public investment advisory firm (subsequently acquired by Lehman Brothers, Holdings, Inc.). Mr. Ferraro serves on the Board of Trustees of the Hackley School, the National Ability Center, and the Utah Committee of the Sundance Institute, the Advisory Council of Cornell University’s Johnson Graduate School of Management, the Board of Directors of the Cayuga MBA Fund, LLC, a $14 million hedge fund managed by students at the Johnson Graduate School of Management at Cornell University and the Advisory Board of the Parker Center for Investment Research at the Johnson Graduate School of Management at Cornell. He also served as a trustee of Blair Academy from 1994 to 2000 and of the Neuberger Museum of Art from 1996 to 1999.

David (Xiao Ying)  Gao
Director - CEO, BMP Sunstone

Mr. Gao has served as BMP Sunstone’s Chief Executive Officer and one of our directors since February 2004. Previously he served as President and Chief Executive Officer of Abacus Investments, Ltd., a private wealth management company, from 2003 to 2004. From 1989 to 2002, Mr. Gao held various senior posts at Motorola including Vice President and Director, Integrated Electronic System Sector, Asia-Pacific operation; Motorola Asia Pacific Management Board, Management Board of Motorola Japan Ltd. and Motorola China Management Board.

Mr. Gao holds a BSC in Mechanical Engineering from the Beijing Institute of Technology, a BSC in Mechanical Engineering from Hanover University, Germany, and an M.B.A. from The Massachusetts Institute of Technology.

Mr. Zhiqiang Han
Director - President

Mr. Han has served as BMP Sunstone’s President of China Operations and one of our directors since February 2008. Mr. Han is the founder of Sunstone (Tangshan) Pharmaceutical Corporation, Ltd. and served as Chairman and General Manager since 1996. From 1993 until1996, Mr. Han served as Managing Director of Tangshan Changrong Pharmaceuticals. Previously, Mr. Han was the Chief EngineerLogistic Dept Head/Assistant to the Plant Director in Tangshan Women and Children Pharmaceutical Manufacturer. Mr. Han serves as Vice President of China Nonprescription Medicine Association; Chairman of Heibei Industry and Economic Union; and Vice President of Hebei Pharmaceutical Industry Association.

Mr. Han has a Bachelor of Science degree from Shenyang Pharmaceutical University and an MBA from Dalian University of Technology.

Frank J. Hollendoner
Director - Doughty Hanson & Co

Frank J. Hollendoner has served as one of our directors since February 2004. Mr. Hollendoner is a private investor. From 2000 to 2004, Mr. Hollendoner served as Chairman of the board of directors of Dr. Foster, a privately-held healthcare information systems company. From 1993 to 2002, Mr. Hollendoner served as Chairman of the board of directors of Doughty Hanson & Co., a London based investment company and buy-out firm. Since 1993 he has served as Chairman of the advisory committee and member of the investment committee of Doughty Hanson & Co. He has served as a director of Ionic Fuel Technology, Inc., a publicly-traded environmental technology company, since 1998. From 1996 to 1998, he served as Chairman of the board of directors of Norden Pac Industries AB. From 1990 to 1998, Mr. Hollendoner served as Executive Chairman of the board of directors of Independent Care Group.

John W. Stakes III, MD
Director - Associate Neurologist, Massachusetts General Hospital

John W. Stakes III, M.D., has served as one of our directors since February 2004. Dr. Stakes has served as an Associate Neurologist at Massachusetts General Hospital since 1990, as Director, Massachusetts General Hospital Sleep Disorders Laboratory, since 1982, and as Director, Specialty Care Development, Massachusetts General Physicians Organization, since 1995. He was a member of the Committee on Continuing Medical Education of the Harvard Medical School. Dr. Stakes has held a teaching position at the Harvard Medical School since 1975.

Zhijun Tong
Director - Chairman of Qifa

Mr. Tong has served as one of our directors since February 2008. He used to work in Beijing municipal government, and keeps very good relationships with relevant divisions there. Mr. Tong Now has served as Chairman of Spain Qifa (investment) Corporation Ltd. since 1997; Chairman of Qifa (Hebei) faming Co., Ltd since 1998; Chairman of Qifa (Liaoning) seeds Center Co., Ltd since 2002; and Vice Chairman/Chairman of Sunstone (Tangshan) Pharmaceutical Co., Ltd since 1996.

Albert Yeung
Director - Former Senior Executive in China for Global Pharmaceutical Companies including J&J, Xian-Janssen, GSK and BMS

Albert Yeung has served as one of our directors since August 2006. Mr. Yeung is President of Albert Yeung & Associates Consulting Co., Ltd. From April 2003 until December 2003, he was a consultant to Glaxo SmithKline China Co., Ltd. From December 1997 through March 2003, Mr. Yeung served as Vice President and General Manager, Tianjin SmithKline & French Co., Ltd. He has 30 years working experience in pharmaceutical marketing and management both in ethical and consumer medicine fields in China and Hong Kong. Mr. Yeung is a co-founder and Honorary Chairman of The Shanghai Psycho-social Rehabilitation Association and Honorary Member of The Shanghai Chinese Traditional and Western Medicine Association.

George Bickerstaff
Director - Managing Director, CRT Capital Group LLC

Mr. Bickerstaff has over two decades of experience in corporate finance, public company reporting, and management and strategic planning. He has held senior financial positions in publicly listed companies, including that of Chief Financial Officer of Novartis Pharma AG from 2000 until May 2005. Mr. Bickerstaff is currently a Managing Director at CRT Capital Group LLC. At CRT, he has played key roles in public offerings and domestic and international transactions, including with China-based, U.S. publicly listed companies. Mr. Bickerstaff started his career at General Electric in manufacturing and finance. He subsequently joined The Dun & Bradstreet Corporation where he held various senior finance positions, including Chief Financial Officer of IMS Health. Additionally, he serves on the boards of directors of Oracle Healthcare Acquisition Corporation (OTCBB: OHAQ) and Vion Pharmaceuticals (NASDAQ: VION). He is also on the board of directors and audit committee of the GAVI Alliance for Vaccines & Immunization Fund, headquartered in Geneva, Switzerland.